Dual <scp>PPAR</scp>α/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental <scp>NASH</scp> models - Concepedia

Concepedia

Publication | Open Access

Dual <scp>PPAR</scp>α/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental <scp>NASH</scp> models

DOI Full Paper Access

197

Citations

17

References

2017

Year

Mukul R. Jain, Suresh Giri, Bibhuti Bhoi, Chitrang Trivedi, Akshyaya Rath, Rohan Rathod, Ramchandra Ranvir, Shekhar Kadam, Hiren Patel, Prabodha Swain,

Liver International

Abstract

Saroglitazar, a dual PPARα/γ agonist with predominant PPARα activity, shows an overall improvement in NASH. The effects of saroglitazar appear better than pure PPARα agonist, fenofibrate and PPARγ agonist pioglitazone.

References

	Year	Citations

Page 1